Nara K, Yamamoto T, Yamashita H, Yagi K, et al. Prior treatment with oxaliplatin-containing regimens and higher total bilirubin
levels are risk factors for neutropenia and febrile neutropenia in patients with
gastric or esophagogastric junction cancer receiving weekly paclitaxel and
ramucirumab the BMC Cancer 2023;23:979.
PMID: 37833660
![]() |
![]() |
![]() |